Cecilia Brain

Cecilia Brain is an experienced medical affairs professional with a robust background in psychiatry and neuroscience. Currently serving as Executive Director of Medical Affairs at Neurocrine Biosciences since October 2025, Cecilia has previously held prominent roles, including Psychiatry Strategy Lead for US Medical Affairs at Lundbeck, and Vice President, Head of Medical Affairs at Axsome Therapeutics, Inc. Significant contributions include leadership in global medical affairs strategies at Jazz Pharmaceuticals and Acadia Pharmaceuticals, where focus areas encompassed neurodegenerative disorders and CNS-related medical marketing. With a clinical foundation as a Senior Psychiatrist and Academic Researcher at Sahlgrenska University Hospital, Cecilia holds an MD from Uppsala University and a Ph.D. in Medicine from the University of Gothenburg.